Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Association of depression and anxiety with cardiovascular co-morbidity in a primary care population in Latvia: a cross-sectional study

Authors: R. Ivanovs, A. Kivite, D. Ziedonis, I. Mintale, J. Vrublevska, E. Rancans

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

Cardiovascular (CV) diseases (CVDs) are the leading cause of mortality worldwide. Globally, there is a growing interest in understanding and addressing modifiable psychosocial risk factors, particularly depression and anxiety, to prevent CVDs and to reduce morbidity and mortality. Despite the high premature mortality rate from CVDs in Latvia, this is the first Latvian study to examine the association of depression and anxiety with CVD morbidity in a primary care population.

Methods

This cross-sectional study was carried out in 2015 within the framework of the National Research Program BIOMEDICINE at 24 primary care facilities throughout Latvia. Consecutive adult patients during a one-week time period at each facility were invited to join the study. Assessments onsite included a 9-item Patient Health Questionnaire (PHQ-9) and a 7-item Generalized Anxiety Disorder scale (GAD-7) followed by a socio-demographic questionnaire and measurements of height, weight, waist circumference, blood pressure, and total cholesterol. The diagnostic Mini International Neuropsychiatric Interview (MINI) was conducted over the telephone within 2 weeks after the visit to the general practitioner. A multivariate model was developed using binary logistic regression.

Results

From the 1565 subjects (31.2% male), CVD was detected in 17.1%. Depression screening was positive (PHQ-9 ≥ 10) for 14.7%, and anxiety screening was positive (GAD-7 ≥ 10) for 10.1% of the study subjects. According to the MINI, 10.3% had current and 28.1% had lifetime depressive episode, and 16.1% had an anxiety disorder. Depression, not anxiety, was statistically significantly related to CVDs with an odds ratio (OR) of 1.52 (p = 0.04) for current depressive symptoms (PHQ-9 ≥ 10) and 2.08 (p = 0.002) for lifetime depressive episode (MINI).

Conclusions

Current depressive symptoms (PHQ-9 ≥ 10) and a lifetime depressive episode (according to the MINI) were significantly associated with increased risk of CV morbidity. Therefore, CV patients should be screened and treated for depression to potentially improve the prognosis of CVDs. Enhanced training and integration of mental health treatment in Latvian primary care settings may improve clinical outcomes.
Literature
1.
Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655–79.CrossRefPubMed
2.
3.
Gili M, Comas A, García-García M, Monzón S, Antoni S-B, Roca M. Comorbidity between common mental disorders and chronic somatic diseases in primary care patients. Gen Hosp Psychiatry. 2010;32(3):240–5.CrossRefPubMed
4.
Roca M, Gili M, Garcia-Garcia M, Salva J, Vives M, Garcia Campayo J, Comas A. Prevalence and comorbidity of common mental disorders in primary care. J Affect Disord. 2009;119(1–3):52–8.CrossRefPubMed
5.
Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry. 2007;29(5):409–16.CrossRefPubMed
6.
Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, Benjet C, Bromet E, de Girolamo G, de Graaf R, et al. Depression-anxiety relationships with chronic physical conditions: results from the world mental health surveys. J Affect Disord. 2007;103(1–3):113–20.CrossRefPubMed
7.
8.
9.
10.
11.
Rutledge T, Linke SE, Krantz DS, Johnson BD, Bittner V, Eastwood JA, Eteiba W, Pepine CJ, Vaccarino V, Francis J, et al. Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's ischemia syndrome evaluation (WISE) study. Psychosom Med. 2009;71(9):958–64.CrossRefPubMedPubMedCentral
12.
Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–69.CrossRefPubMed
13.
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–105.CrossRefPubMed
14.
Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(6):1330–40.CrossRefPubMed
15.
Hackett ML, Pickles K. Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J of stroke : official J of the Int Stroke Society. 2014;9(8):1017–25.CrossRef
16.
Lane D, Carroll D, Ring C, Beevers DG, Lip GY. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol. 2002;7(Pt 1):11–21.CrossRefPubMed
17.
Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies. Int J of stroke : official J of the Int Stroke Society. 2013;8(7):545–59.CrossRef
18.
Todaro JF, Shen BJ, Raffa SD, Tilkemeier PL, Niaura R. Prevalence of anxiety disorders in men and women with established coronary heart disease. J of cardiopulmonary rehabilitation and prevention. 2007;27(2):86–91.CrossRef
19.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & rehabilitation (EACPR). Atherosclerosis. 2016;252:207–74.CrossRefPubMed
20.
Gan Y, Gong Y, Tong X, Sun H, Cong Y, Dong X, Wang Y, Xu X, Yin X, Deng J, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC psychiatry. 2014;14:371.CrossRefPubMedPubMedCentral
21.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.CrossRefPubMed
22.
Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27(23):2763–74.CrossRefPubMed
23.
Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306(11):1241–9.CrossRefPubMedPubMedCentral
24.
Frasure-Smith N, Lesperance F. Depression and cardiac risk: present status and future directions. Heart. 2010;96(3):173–6.CrossRefPubMed
25.
Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011;33(3):203–16.CrossRefPubMed
26.
Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice. J Am Coll Cardiol. 2005;45(5):637–51.CrossRefPubMed
27.
Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010;56(1):38–46.CrossRefPubMed
28.
Batelaan NM, Seldenrijk A, Bot M, van Balkom AJ, Penninx BW. Anxiety and new onset of cardiovascular disease: critical review and meta-analysis. The British J of psychiatry : the J of mental sci. 2016;208(3):223–31.CrossRef
29.
Meyer T, Buss U, Herrmann-Lingen C. Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosom Med. 2010;72(1):9–15.CrossRefPubMed
30.
Meyer T, Hussein S, Lange HW, Herrmann-Lingen C. Anxiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting. Eur J Prev Cardiol. 2015;22(1):75–82.CrossRefPubMed
31.
Emdin CA, Odutayo A, Wong CX, Tran J, Hsiao AJ, Hunn BHM. Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am J Cardiol. 2016;118(4):511–9.CrossRefPubMed
32.
Ian G, Dan A, Knut B-J, Gudrun B, Gunilla B, Renata C, Jean D, Guy De B, Shah E, Bjørn G, et al. Fourth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14(2):E1–E40.
33.
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635–701.CrossRefPubMed
34.
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. European J of cardiovascular prevention and rehabilitation : official J of the European Society of Cardiology, Working Groups on Epidemiol and Prevention and Cardiac Rehabilitation and Exercise Physiol. 2009;16(2):121–37.CrossRef
35.
Kotseva K, De Bacquer D, De Backer G, Ryden L, Jennings C, Gyberg V, Abreu A, Aguiar C, Conde AC, Davletov K, et al. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on secondary and primary prevention by intervention to reduce events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol. 2016;23(18):2007–18.
36.
Erglis A, Dzerve V, Pahomova-Strautina J, Narbute I, Jegere S, Mintale I, Ligere R, Apinis P, Lejnieks A, Misina D, et al. A population-based cross-sectional study of cardiovascular risk factor in Latvia. Med (Kaunas, Lithuania). 2012;48(6):310–6.
37.
Viigimaa M, Erglis A, Latkovskis G, Maeots E, Petrulioniene Z, Slapikas R, Gocentiene A, Bramlage P, Brudi P. Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): results of the dyslipidemia international study (DYSIS). Med (Kaunas, Lithuania). 2014;50(1):44–53.
38.
Burokienė N, Karčiauskaitė D, Kasiulevičius V, Kučinskas V, Kučinskienė ZA. Manifestation of anxiety and depression and their association with cardiovascular diseases in the Lithuanian population. Acta Medica Lituanica. 2014;21(3):123–30.
39.
Suija K, Kalda R, Maaroos H-I. Patients with depressive disorder, their co-morbidity, visiting rate and disability in relation to self-evaluation of physical and mental health: a cross-sectional study in family practice. BMC Fam Pract. 2009;10:38.CrossRefPubMedPubMedCentral
40.
Assari S. Cross-country differences in the additive effects of socioeconomics, health behaviors and medical comorbidities on disability among older adults with heart disease. The J of Tehran University Heart Center. 2015;10(1):24–33.
41.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA. 1999;282(18):1737–44.CrossRefPubMed
42.
43.
Meader N, Mitchell AJ, Chew-Graham C, Goldberg D, Rizzo M, Bird V, Kessler D, Packham J, Haddad M, Pilling S. Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies. The British J of general practice : the J of the Royal College of General Practitioners. 2011;61(593):e808–20.CrossRef
44.
Haddad M, Walters P, Phillips R, Tsakok J, Williams P, Mann A, Tylee A. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK study. PLoS One. 2013;8(10):e78493.CrossRefPubMedPubMedCentral
45.
Rancans E, Vrublevska J, Trapencieris M, Snikere S, Ivanovs R, Logins R, Berze L. P.2.H.016 - validity of patient health questionnaire (PHQ-9) in detecting depression in primary care settings in Latvia – the results of the National Research Project BIOMEDICINE. Eur Neuropsychopharmacol. 2016;26(l):481.CrossRef
46.
Vrublevska J, Trapencieris M, Rancans E. Adaptation and validation of the patient health Questionnaire-9 to evaluate major depression in a primary care sample in Latvia. Nordic J Of Psychiatry. 2018;72(2):112–8.
47.
Swinson RP. The GAD-7 scale was accurate for diagnosing generalised anxiety disorder. Evidence-based med. 2006;11(6):184.CrossRef
48.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMed
49.
Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–25.CrossRefPubMed
50.
Conway A, Sheridan J, Maddicks-Law J, Fulbrook P, Ski CF, Thompson DR, Doering LV. Accuracy of anxiety and depression screening tools in heart transplant recipients. Applied nursing research : ANR. 2016;32:177–81.CrossRefPubMed
51.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The J of clin psychiatry. 1998;59(Suppl 20):22–33.
52.
Boudrot A, Sheehan D, Acquadro C. Lost in translation: translatability of psychiatric terms-the example of the Mini-international neuropsychiatric interview (M.I.N.I.). Value Health. 2013;16(7):A599–A599.
53.
Kasmel A, Helasoja V, Lipand A, Prättälä R, Klumbiene J, Pudule I. Association between health behaviour and self-reported health in Estonia, Finland, Latvia and Lithuania. Eur J Pub Health. 2004;14(1):32–6.CrossRef
54.
Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med. 2002;23(1):51–61.CrossRefPubMed
55.
Meeks TW, Vahia IV, Lavretsky H, Kulkarni G, Jeste DV. A tune in ‘a minor’ can ‘b major’: a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults. J Affect Disord. 2011;129(1–3):126–42.CrossRefPubMedPubMedCentral
56.
Goldstein CM, Gathright EC, Garcia S. Relationship between depression and medication adherence in cardiovascular disease: the perfect challenge for the integrated care team. Patient preference and adherence. 2017;11:547–59.CrossRefPubMedPubMedCentral
57.
Doyle F, Rohde D, Rutkowska A, Morgan K, Cousins G, McGee H. Systematic review and meta-analysis of the impact of depression on subsequent smoking cessation in patients with coronary heart disease: 1990 to 2013. Psychosom Med. 2014;76(1):44–57.CrossRefPubMed
58.
Swardfager W, Herrmann N, Marzolini S, Saleem M, Farber SB, Kiss A, Oh PI, Lanctot KL. Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease. The J of clin psychiatry. 2011;72(9):1181–8.CrossRef
59.
Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the heart and soul study. Arch Intern Med. 2005;165(21):2508–13.CrossRefPubMedPubMedCentral
60.
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7.CrossRefPubMed
61.
62.
Pogosova N, Saner H, Pedersen SS, Cupples ME, McGee H, Hofer S, Doyle F, Schmid JP, von Kanel R. Psychosocial aspects in cardiac rehabilitation: from theory to practice. A position paper from the cardiac rehabilitation section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol. 2015;22(10):1290–306.CrossRefPubMed
63.
Penninx BW. Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017;74(Pt B):277–86.CrossRefPubMed
64.
65.
APA. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Washington, DC: American Psychiatric Association; 2013.
66.
Bandelow B, Baldwin D, Abelli M, Altamura C, Dell'Osso B, Domschke K, Fineberg NA, Grunblatt E, Jarema M, Maron E, et al. Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: neuroimaging and genetics. The world J of biol psychiatry: the official J of the World Federation of Societies of Biol Psychiatry. 2016;17(5):321–65.CrossRef
67.
Khalid A, Kunwar AR, Rajbhandari KC, Sharma VD, Regmi SK. A study of prevalence and comorbidity of depression in alcohol dependence. Indian J Psychiatry. 2000;42(4):434–8.PubMedPubMedCentral
68.
Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, Breslau N, Brown RA, George TP, Williams J, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research: Official J Of The Society For Research On Nicotine And Tobacco. 2008;10(12):1691–715.CrossRef
69.
Pacek LR, Storr CL, Mojtabai R, Green KM, La Flair LN, Alvanzo AAH, Cullen BA, Crum RM. Comorbid alcohol dependence and anxiety disorders: a National Survey. J of dual diagnosis. 2013;9(4):271–80.CrossRef
70.
Figueiredo JHC, NAdSe S, BdB P, GMM d O. Major Depression and Acute Coronary Syndrome-Related Factors. Arq Bras Cardiol. 2017;108(3):217–27.PubMedPubMedCentral
71.
Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–27.CrossRefPubMed
72.
Kalvelis A, Stukena I, Bahs G, Lejnieks A. Do we correctly assess the risk of cardiovascular disease? Characteristics of risk factors for cardiovascular disease depending on the sex and age of patients in Latvia. European J of Cardiovascular Med. 2011;3:19–23.
73.
Erglis A, Mintale I, Latkovskis G, Balode I, Jegere S, Bajare I, Rozenbergs A, Greenlaw N, Ferrari R, Steg PG. Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: analysis of the CLARIFY registry. Medicina. 2015;51(4):240–6.CrossRefPubMed
74.
Thombs BD, Ziegelstein RC, Whooley MA. Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study. J Gen Intern Med. 2008;23(12):2014–7.CrossRefPubMedPubMedCentral
Metadata
Title
Association of depression and anxiety with cardiovascular co-morbidity in a primary care population in Latvia: a cross-sectional study
Authors
R. Ivanovs
A. Kivite
D. Ziedonis
I. Mintale
J. Vrublevska
E. Rancans
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5238-7

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue

Research article

Re-look at socioeconomic inequalities in stroke prevalence among urban Chinese: is the inflexion approaching?

Study protocol

Study protocol: a randomised controlled trial of supervised resistance training versus aerobic training in Sri Lankan adults with type 2 diabetes mellitus: SL-DART study

Research article

Intimate partner violence, forced first sex and adverse pregnancy outcomes in a sample of Zimbabwean women accessing maternal and child health care

Study protocol

A hybrid design testing a 3-step implementation model for community scale-up of an HIV prevention intervention in rural Malawi: study protocol

Research article

Sports participation and psychosocial health: a longitudinal observational study in children

Research article

Trained lay health workers reduce common mental disorder symptoms of adults with suicidal ideation in Zimbabwe: a cohort study